Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Your search for Myleofibrosis (patient information) AND systematic[sb] retrieved no results
Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis.
Sureau L, Orvain C, Ianotto JC, Ugo V, Kiladjian JJ, Luque Paz D, Riou J. Sureau L, et al. Blood Cancer J. 2021 Jul 27;11(7):135. doi: 10.1038/s41408-021-00526-z. Blood Cancer J. 2021. PMID: 34315858 Free PMC article.
Janus kinase (JAK) inhibitors have been used for the treatment of myelofibrosis for several years, but there is a lack of comparative information between those treatments. A systematic review and network meta-analysis was performed on randomized controlled trials in …
Janus kinase (JAK) inhibitors have been used for the treatment of myelofibrosis for several years, but there is a lack of comparative …
Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000-2018.
Mejía-Ochoa M, Acevedo Toro PA, Cardona-Arias JA. Mejía-Ochoa M, et al. BMC Cancer. 2019 Jun 17;19(1):590. doi: 10.1186/s12885-019-5764-4. BMC Cancer. 2019. PMID: 31208359 Free PMC article.
In addition, no systematization of studies of polycythemia vera (PV), essential thrombocythemia (ET) or primary myelofibrosis (PMF) have been carried out. The objective of this review is to characterize studies on BCR-ABL1-negative chronic myeloproliferative neoplas …
In addition, no systematization of studies of polycythemia vera (PV), essential thrombocythemia (ET) or primary myelofibrosis
Outcomes and Clinical Characteristics of Intracranial Hemorrhage in Patients with Hematologic Malignancies: A Systematic Literature Review.
Raghavan A, Wright CH, Wright JM, Jensen K, Malloy P, Elder T, Burant C, Sajatovic M, Hoffer A. Raghavan A, et al. World Neurosurg. 2020 Dec;144:e15-e24. doi: 10.1016/j.wneu.2020.06.091. Epub 2020 Jun 18. World Neurosurg. 2020. PMID: 32565374
Understanding the influence of these factors on patient survival can guide treatment decisions and may inform prognostic discussions. ...RESULTS: Literature review yielded 975 abstracts from which a total of 68 full-text articles were reviewed. Twelve articles captu …
Understanding the influence of these factors on patient survival can guide treatment decisions and may inform prognostic discu …
The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review.
Slot S, van de Donk NWCJ, Otten RHJ, Boden BJH, Zijlstra J, Raijmakers PGHM, Zweegman S. Slot S, et al. Cancer Imaging. 2021 Apr 20;21(1):36. doi: 10.1186/s40644-021-00405-7. Cancer Imaging. 2021. PMID: 33879266 Free PMC article.
Although not currently used in clinical practice, imaging techniques might offer additional information. In this review, we investigated the value of BM, liver, and spleen imaging for diagnosis, prognostication, and response monitoring of the JAK2/CALR/MPL mutation-related …
Although not currently used in clinical practice, imaging techniques might offer additional information. In this review, we investiga …